Categories Nevin Manimala Statistics Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19 Post author By Nevin Manimala Post date December 20, 2022 Pharmacol Res Perspect. 2023 Feb;11(1):e01036. doi: 10.1002/prp2.1036. NO ABSTRACT PMID:36537346 | DOI:10.1002/prp2.1036 Tags nevin manimala, pubmed, statistics By Nevin Manimala Portfolio Website for Nevin Manimala View Archive → ← Changes in anemia status in Mexican children: a longitudinal study → On the Double-Robustness and Semiparametric Efficiency of Matching-Adjusted Indirect Comparisons